Hasil Pencarian - Halpin DMG
- Menampilkan 1 - 10 hasil dari 10
-
1
When is dual bronchodilation indicated in COPD? oleh Thomas M, Halpin DMG, Miravitlles M
Diterbitkan 2017-08-01
Artikel -
2
Impact and prevention of severe exacerbations of COPD: a review of the evidence oleh Halpin DMG, Miravitlles M, Metzdorf N, Celli B
Diterbitkan 2017-10-01
Artikel -
3
Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis oleh Halpin DMG, Dahl R, Hallmann C, Mueller A, Tashkin D
Diterbitkan 2015-02-01
Artikel -
4
Exacerbation frequency and course of COPD oleh Halpin DMG, Decramer M, Celli B, Kesten S, Liu D, Tashkin DP
Diterbitkan 2012-09-01
Artikel -
5
Preference for different relaxation techniques by COPD patients: comparison between six techniques oleh Hyl, ME, Halpin DMG, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves CJ, Hawkins AL, Seamark D
Diterbitkan 2016-09-01
Artikel -
6
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD oleh Bourbeau J, Bafadhel M, Barnes NC, Compton C, Di Boscio V, Lipson DA, Jones PW, Martin N, Weiss G, Halpin DMG
Diterbitkan 2021-03-01
Artikel -
7
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial oleh Ismaila AS, Risebrough N, Schroeder M, Shah D, Martin A, Goodall EC, Ndirangu K, Criner G, Dransfield M, Halpin DMG, Han MK, Lomas DA
Diterbitkan 2019-11-01
Artikel -
8
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease oleh Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS
Diterbitkan 2022-01-01
Artikel -
9
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD oleh Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB
Diterbitkan 2020-11-01
Artikel -
10
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial oleh Gabrio A, Gunsoy NB, Baio G, Martin A, Paly VF, Risebrough N, Halpin DMG, Singh D, Wise RA, Han MK, Martinez FJ, Criner GJ, Martin N, Lipson DA, Ismaila AS
Diterbitkan 2022-07-01
Artikel